Condition: Thoracic Surgery · Pneumonectomy · Lobectomy · Sponsor: OpalGenix, Inc
The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone, in adults following thoracic surgery. Major inpatient thoracic surgeries (TS) for lung disease are common and extremely painful surgeries and are associated with sever post-surgical pain, high incidence of chronic post-surgical pain (CPSP), excess opioid use, costly immediate postoperative opioid adverse events (AEs), and long hospital stays. This study is aiming to develop proactive risk prediction algorithms for precision surgical pain relief in adult TS patients through comparison of actual clinical outcomes with standard of care to predicted outcomes based on personalized risk assessments.
This description comes directly from the study's public registry record.
Amy Monroe, MPH, MBA · 412-623-6382 · monroeal@upmc.edu
Alisha Maslanka, BS · 412-864-6779 · maslankaaa@upmc.edu
Always discuss trial participation with your own doctor first.
| UPMC Presbyterian Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| UPMC Mercy Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| UPMC Shadyside Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| UPMC Passavant Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05525923